
Please try another search
Biomind Labs Inc. is a Canada-based biotech research and development company. The Company is focused on developing the pharmaceuticals to treat patients suffering from neurological and psychiatric disorders by scientifically harnessing the medicinal power of psychedelic molecules. Through its platform, the Company is engaged in the development of pharmaceutical formulations of the main psychedelic molecules, DMT, 5-MeO-DMT (2-(5-Methoxy-1H-indol-3-yl)-N, N-dimethyltryptamine) and mescaline 2-(3,4,5-trimethoxyphenyl)-ethylamine for treating a range of therapeutic indications. 5-MeO-DMT is a psychotropicbiomolecule from the tryptamine class. 5-MeO-DMT is a potent agonist on 5-HT1A and 5-HT2A receptors. Ayahuasca is a psychoactive beverage that contains, as active ingredients, a complex mixture of alkaloids composed mainly by DMT and the β-carbolines harmine, harmaline and tetrahydroharmine. Mescaline is a phenylethylamine alkaloid structurally related to the neurotransmitter dopamine.
Name | Age | Since | Title |
---|---|---|---|
Ben Illigens | 47 | 2021 | Director |
Ravi Sood | 45 | 2021 | Chairman of the Board |
Alejandro Antalich | 48 | 2021 | CEO & Director |
Fraser Alexander Buchan | 38 | 2021 | Director |
Oscar Alejandro Leon | 62 | 2021 | CFO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review